STEM CELL AGENCY MEETING NOTICE AND AGENDA

REGULAR MEETING OF THE
INDEPENDENT CITIZENS’ OVERSIGHT COMMITTEE
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

Thursday, March 11th, 2010
9:30 AM-1:00 PM (Estimated)

Locations:

State Capitol Building
Room 4202
Sacramento, CA 95814

330 Plaza St.
Healdsburg, CA 95448
 

409 North Larchmont Blvd
Los Angeles, CA 90004
 

URL: http://65.197.1.15/att/confcast
Confirmation: 149707

1. Call to Order.

2. Pledge of Allegiance.

3. Roll Call.

[Members of the Public will be invited to provide testimony before or during consideration of each item. Makers of public comments are asked to limit their testimony to three (3) minutes.]

REPORTS

4. Chairman’s Report.

5. President’s Report.

• Budget & Expenditure Report

CONSENT CALENDAR

6. Consideration of minutes from previous ICOC meetings.

A. Draft minutes from December 2008 ICOC Meeting.

B. Draft minutes from January 2009 ICOC Meeting.

C. Draft minutes from April 2009 ICOC Meeting.

D. Draft minutes from February 2010 ICOC Meeting.

ACTION ITEMS

7. Consideration of proposal to approve increase in the amount of funding for Early Translational Research Award No. TR1-01267.

8. Consideration of concept proposal for targeted Request for Applications for Clinical Development.

9. Consideration of new alternate members for Grants Working group.

10. Consideration of recommendations from Legislative Subcommittee regarding SB 1064 (Alquist) and AB 52 (Portantino)

A. Legislative Counsel's Digest

B. Bill Analysis

C. Letter to Senator Alquist

D. Memo from Remcho, Johansen & Purcell

E. Memo from NIELSEN, MERKSAMER,
PARRINELLO, MUELLER & NAYLOR, LLP

F. Letter and Proposal from Assemblymember Portantino

11. Consideration of resolution regarding Stuart Orkin, former Chair of Grants Working Group.

CLOSED SESSION

12. Discussion of Personnel (Government Code section 11126, subdivision (a); Health & Safety Code section 125290.30(d) (3) (D)).

Public report of any action taken, if necessary, during closed session.

ACTION ITEMS

13. Consideration of compensation of Vice President of Research & Development.

DISCUSSION ITEMS

14. Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov .